Dr. Cappelli is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4940 Eastern Avenue
Bayview Medical Offices, Level 01 (G), Clinic 5
Baltimore, MD 21224Phone+1 443-997-1552Fax+1 410-550-1033
Summary
- I am a rheumatologist in academic medicine. I see patients with inflammatory arthritis and perform clinical research. My main clinical and research interest is rheumatic immune-related adverse events from immune checkpoint inhibitor therapies used to treat cancer. I also perform clinical and translational research in rheumatoid arthritis.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2013 - 2016
Johns Hopkins Bloomberg School of Public HealthMHS, 2014 - 2015- Johns Hopkins UniversityResidency, Internal Medicine, 2010 - 2013
- Johns Hopkins University School of MedicineClass of 2010
Certifications & Licensure
FL State Medical License 2020 - Present
MD State Medical License 2015 - 2026
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Rheumatology
Publications & Presentations
PubMed
- 3 citationsImmune-related encephalitis after immune checkpoint inhibitor therapy.Monica W Buckley, Aanika Balaji Warner, Julie Brahmer, Laura C Cappelli, William H Sharfman
The Oncologist. 2025-01-17 - 1 citationsImmune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures.Chester J Kao, Soren Charmsaz, Stephanie L Alden, Madelena Brancati, Howard L Li
The Journal of Clinical Investigation. 2024-08-29 - 1 citationsImmune checkpoint inhibitor therapy in patients with cancer and pre-existing systemic sclerosis.Rachel S Wallwork, Jonathan J Kotzin, Laura C Cappelli, Christopher Mecoli, Clifton O Bingham 3rd
Seminars in Arthritis and Rheumatism. 2024-08-01
Press Mentions
Toxic Trade-OffsMarch 16th, 2023- Highlights from the ACR Review Course 2022December 6th, 2022
- 5 Tips for Getting the Most Out of Your Next Rheumatoid Arthritis AppointmentMarch 10th, 2021
- Join now to see all
Grant Support
- Evaluating the relationship between immune checkpoint inhibitors and osteoarthritisJOHNS HOPKINS UNIVERSITY2023–2025
- Understanding Inflammatory Arthritis due to Immune Checkpoint InhibitorsJOHNS HOPKINS UNIVERSITY2019–2025
- Understanding Inflammatory Arthritis due to Immune Checkpoint InhibitorsJOHNS HOPKINS UNIVERSITY2019–2025
- Understanding Inflammatory Arthritis due to Immune Checkpoint InhibitorsJOHNS HOPKINS UNIVERSITY2019–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
